ThursdayAug 27, 2026 3:38 pm

QualityStocksNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Moves Myelin-Protecting MS Therapy to Phase 2 Development

Disseminated on behalf of Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) and may include paid advertising. Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) is a biopharmaceutical company focused on advancing innovative therapies and technologies. The company was featured in a recent article that discussed its efforts to advance Lucid-MS, an oral investigational therapy designed to inhibit demyelination and protect myelin in people with multiple sclerosis, as MS drug development increasingly expands beyond controlling inflammation toward neuroprotection and myelin preservation. Preclinical studies demonstrated myelin preservation and functional recovery in animal models, while the company’s Phase 1 program generated safety and pharmacokinetic data supporting further development. The U.S.…

Continue Reading

ThursdayAug 27, 2026 3:07 pm

QualityStocksNewsBreaks – Regentis Biomaterials Ltd. (NYSE American: RGNT) Expands GelrinC Clinical and Commercial Pathways

Regentis Biomaterials (NYSE American: RGNT) is advancing its GelrinC cell-free cartilage repair implant along parallel U.S. clinical and European commercial tracks, with more than half of the 80-patient pivotal Phase III SAGE study enrolled and recruitment targeted for completion in the third quarter of 2026. The FDA-approved single-arm study uses a historical microfracture control dataset owned by Regentis, and the company reports that the first 40 enrolled patients closely match the historical control group in baseline characteristics. In Europe, where GelrinC already has CE Mark approval, Regentis is preparing for broader commercialization through surgeon training, an expanding network of Centers of Excellence…

Continue Reading

ThursdayAug 27, 2026 2:29 pm

QualityStocksNewsBreaks – Earth Science Tech Inc. (ETST) Marks Growth as Avenvi Expands Asset Base

Earth Science Tech (OTC: ETST) was featured in a recent article that discussed its strengthened position among OTC-listed companies through consistent financial growth, timely reporting, vertical integration, prudent capital allocation, and ownership of hard real estate assets. Revenue increased to $35.7 million in FY2026 from $33.1 million in FY2025 and $11.95 million in FY2024, while gross profit rose to $25.5 million from $24.3 million and $7.8 million. The company attributes this progress to strategic investments and acquisitions made without adding debt, particularly its purchase of Avenvi, a real estate company whose 13-property portfolio includes the Texas property housing ETST’s Mister Meds…

Continue Reading

FridayAug 21, 2026 3:45 pm

QualityStocksNewsBreaks – Market Street Capital Inc. Helps Founders Navigate Expanding Private Credit Landscape

Market Street Capital was featured in a recent article that discusses how the expanding private credit sector is giving middle-market founders more options when evaluating debt and equity financing. The article explores the long-term implications of each approach, noting that debt can preserve ownership and provide cost-efficient capital for established businesses with predictable cash flows, while equity can offer greater flexibility for transformational initiatives but comes with ownership dilution and potential changes in governance. As traditional bank lending remains less accessible to some middle-market companies, private credit has emerged as an increasingly important source of financing through structures such as senior…

Continue Reading

ThursdayAug 20, 2026 2:10 pm

QualityStocksNewsBreaks – MindWave Innovations Inc.’s (NYSE American: APUS) MindChain Brings Enterprise Customization to Ethereum L2

MindWave Innovations (NYSE American: APUS) is positioning MindChain as an enterprise-focused Ethereum-compatible Layer 2 designed to give organizations greater control over blockchain infrastructure while retaining Ethereum settlement and security. The network will use company-operated sequencer and validator infrastructure, with NILA becoming the native token for transaction fees, staking and network security. MindWave also plans industry-specific subnets for areas such as insurance, climate technology, advertising and real-world assets, alongside developer tools intended to simplify enterprise adoption. With NILA now accessible to U.S. users through Webot and a MindChain mainnet launch targeted for October 2026, the company’s broader thesis is that the next…

Continue Reading

ThursdayAug 20, 2026 1:22 pm

QualityStocksNewsBreaks – SS Innovations International Inc. (NASDAQ: SSII) Combines Medtech Leadership, Surgeon Training to Drive Robotic Surgery Expansion

SS Innovations International (NASDAQ: SSII) recently appointed veteran medtech finance executive Sarah M. Romano as chief financial officer, strengthening the company’s leadership and global growth strategy. Romano brings more than two decades of finance and capital markets experience, including more than $100 million raised through public and private financings, as SS Innovations advances U.S. FDA clearance efforts for its SSi Mantra robotic surgical system and expands internationally. The company is also investing in surgeon education through its SS International Centre for Robotics Surgery, which recently graduated its first cardiac robotic training class of 33 healthcare professionals from seven countries. Together, the…

Continue Reading

WednesdayAug 19, 2026 2:32 pm

QualityStocksNewsBreaks – Beeline Holdings Inc. (NASDAQ: BLNE) Advances Digital Strategy with AI and Automation

Beeline Holdings (NASDAQ: BLNE), a technology-driven mortgage lender and fractional equity platform, was featured in a recent article that discussed continued expansion during a period of ongoing change in the U.S. housing market. The piece highlights a strategy that centers on “reducing friction throughout the mortgage process.” The company’s proprietary technology platform incorporates “its AI-powered virtual assistant, Bob, together with its production engine known as Hive,” while its AI-driven underwriting platform can provide “an initial qualification assessment in roughly seven to eight minutes while delivering approximately 90% certainty regarding mortgage eligibility.” According to the company, “loans can close in approximately…

Continue Reading

WednesdayAug 19, 2026 1:45 pm

QualityStocksNewsBreaks – SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) Brings Solutions to Growing Challenges in Modern Warfare

Disseminated on behalf of SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) and may include paid advertising. SPARC AI (CSE: SPAI) (OTCQB: SPAIF) was featured in a recent article that discussed efforts to position its Overwatch and ATLAS software platforms as potential solutions to growing battlefield challenges posed by GPS-denied environments, where jamming and spoofing are increasingly affecting drones, aircraft and autonomous systems. The article points to a $49.7 million Air Force Research Laboratory contract focused on technologies capable of operating without GPS, as well as increasing reports of GPS disruptions in conflict zones, as evidence that alternative navigation is becoming a defense priority.…

Continue Reading

WednesdayAug 19, 2026 1:00 pm

QualityStocksNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Explores Myelin Protection as New Focus in MS Treatment

Disseminated on behalf of Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) and may include paid advertising. Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) is developing Lucid-MS around the idea that multiple sclerosis disability can progress independently of relapses, known as progression independent of relapse activity (“PIRA”). A recent article discusses chronic active, or “smoldering,” lesions and compartmentalized inflammation within the central nervous system as potential contributors to ongoing tissue damage that may not be adequately addressed by therapies focused primarily on peripheral immune activity. Lucid-MS takes a different approach by targeting myelin degradation, with the goal of preserving myelin and supporting functional recovery rather than broadly…

Continue Reading

TuesdayAug 18, 2026 3:32 pm

QualityStocksNewsBreaks – Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) Steps Up Cameron REE Exploration with 2026 Field Program

Disseminated on behalf of Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) and may include paid advertising.  Powermax Minerals (CSE: PMAX) (OTCQB: PWMXF) has commenced its 2026 exploration program at its 100%-owned Cameron Rare Earth Element (“REE”) Project in British Columbia, building on encouraging findings from previous exploration campaigns. The three-week program will combine geological mapping and prospecting with rock, soil and stream sediment sampling, ground radiometric surveys and integrated data analysis to refine REE target corridors, identify potential bedrock sources and prioritize areas for future trenching and first-pass drilling. Earlier Phase 1 and 2 exploration identified enrichment of both light and heavy rare earth elements…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered